Covington & Burling advised the Special Conflicts Committee of the Board of Directors of Atlas Pipeline Partners in its $5.8 billion merger with Targa Resources Partners. More >>

Cravath represented the underwriters, led by Morgan Stanley, BofA Merrill Lynch, Wells Fargo Securities, Barclays, Citigroup, Credit Suisse and Deutsche Bank Securities, in connection with the US$850 million and US$525 million registered high‑yield senior debt offerings of United Rentals (North America) Inc. (URNA), the largest equipment rental company in the world at the time of the offering. URNA intends to use the net proceeds from these offerings to finance its acquisition of National Pump, a specialty pump and industrial equipment rental businesses, and refinance existing indebtedness. The offerings closed on March 26, 2014. More >>

DLA Piper has advised Synergy Health plc (“Synergy”), a leading global supplier of outsourced services to healthcare providers and other customers concerned with health management, on its recommended combination with STERIS Corporation (“STERIS”), a major provider of infection prevention and other procedural products and services focussed primarily on healthcare, pharmaceutical and research markets. The transaction, which was announced this morning, values Synergy at $1.9 billion, and the combined group at $5.2 billion. More >>

Paul Hastings LLP, a leading global law firm, represented Ivanhoé Cambridge, the second largest pension fund in Canada, in the creation of a new partnership with Black Creek Group (Black Creek), a real estate private equity firm with extensive experience sponsoring real estate companies in Mexico.

Ivanhoé Cambridge, a real estate subsidiary of institutional fund manager Caisse de dépôt et placement du Québec, together with Black Creek, will invest in the development of mixed-use urban communities in the main cities of Mexico including Mexico City, Monterrey and Guadalajara through MIRA, Black Creek’s fully-integrated real estate and development platform in Mexico. Ivanhoé Cambridge intends to invest up to US$500 million in assets, as part of its strategy of developing a long-term active presence in growth markets. More >>

Willkie client Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, entered into a definitive merger agreement to be acquired by Endo International plc for a combination of cash and stock which values Auxilium at approximately $2.6 billion. The signing of the merger agreement follows Auxilium’s receipt on September 12 of an unsolicited, non-binding proposal from Endo. In connection with the signing of the merger agreement, the board of directors of Auxilium determined that the merger agreement with Endo constituted a superior proposal under the terms of Auxilium’s existing merger agreement with QLT Inc. and terminated the QLT merger agreement. More >>